GAZZERRO, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 4.300
AS - Asia 4.248
EU - Europa 1.685
SA - Sud America 182
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 10.429
Nazione #
US - Stati Uniti d'America 4.262
HK - Hong Kong 2.945
CN - Cina 489
IT - Italia 446
SG - Singapore 430
UA - Ucraina 298
RU - Federazione Russa 277
DE - Germania 210
VN - Vietnam 173
BR - Brasile 162
IE - Irlanda 133
SE - Svezia 111
FI - Finlandia 93
TR - Turchia 75
KR - Corea 59
GB - Regno Unito 34
IN - India 33
CZ - Repubblica Ceca 24
CA - Canada 20
AT - Austria 14
ES - Italia 10
FR - Francia 10
MX - Messico 9
BD - Bangladesh 7
PL - Polonia 7
UZ - Uzbekistan 6
IL - Israele 5
IQ - Iraq 5
JP - Giappone 5
NL - Olanda 5
AR - Argentina 4
BE - Belgio 4
PE - Perù 4
PY - Paraguay 4
EC - Ecuador 3
JO - Giordania 3
RO - Romania 3
AU - Australia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
HN - Honduras 2
JM - Giamaica 2
MA - Marocco 2
PK - Pakistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DJ - Gibuti 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
KH - Cambogia 1
LT - Lituania 1
MY - Malesia 1
NA - Namibia 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 10.429
Città #
Hong Kong 2.942
Ann Arbor 1.121
Chandler 533
Jacksonville 362
Princeton 355
Woodbridge 318
Wilmington 237
Houston 189
Singapore 185
Dong Ket 161
Dublin 133
Ashburn 130
Beijing 112
Nanjing 100
Munich 98
Salerno 88
Boardman 82
Andover 79
Izmir 69
Pellezzano 56
Moscow 53
Mestre 35
Los Angeles 33
Fairfield 32
Dearborn 31
Jiaxing 29
Nanchang 28
Hebei 27
Naples 26
Norwalk 25
Shenyang 24
Brno 23
Shanghai 22
Pune 19
Turku 19
Cava de' Tirreni 16
Dallas 16
Düsseldorf 15
Jinan 15
Redwood City 14
São Paulo 14
Changsha 13
The Dalles 13
Zhengzhou 13
Helsinki 12
Nuremberg 12
Tianjin 12
Columbus 11
Cambridge 10
San Francisco 10
Seattle 10
Vienna 10
Washington 10
Council Bluffs 9
Boston 8
Qualiano 8
Santa Clara 8
Brooklyn 7
Falls Church 7
Guangzhou 7
Ottawa 7
Chennai 6
Chicago 6
Florence 6
Lappeenranta 6
Milan 6
Napoli 6
San Diego 6
San Miniato Basso 6
Stockholm 6
Warsaw 6
Brasília 5
Nürnberg 5
Rome 5
Sarno 5
Tashkent 5
Tokyo 5
Atlanta 4
Brussels 4
Campinas 4
Duncan 4
Ferrandina 4
Hangzhou 4
Hanoi 4
Ho Chi Minh City 4
Indiana 4
Mexico City 4
Montreal 4
New York 4
Philadelphia 4
San Nicola la Strada 4
West Jordan 4
Wuhan 4
Amsterdam 3
Baghdad 3
Belo Horizonte 3
Carney 3
Chengdu 3
Chiswick 3
Curitiba 3
Totale 8.238
Nome #
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 1.229
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. 923
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux 259
Immuno-modulatory and anti-inflammatory effects of dihydrogracilin a, a terpene derived from the marine sponge Dendrilla membranosa 247
Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation 222
Pharmacological actions of statins: a critical appraisal in the management of cancer. 214
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation 203
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway 199
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. 172
Annurca peel extract: from the chemical composition, through the functional activity, to the formulation and characterisation of a topical oil-in-water emulsion 166
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 146
Structural Evidence ofN6-Isopentenyladenosine As a New Ligand of Farnesyl Pyrophosphate Synthase 143
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. 141
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 141
Update on the endocannabinoid system as an anticancer target. 133
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 128
HRMS Profile of a Hazelnut Skin Proanthocyanidin-rich Fraction with Antioxidant and Anti-Candida albicans Activities 128
Chemical profile and cellular antioxidant activity of artichoke by-products 125
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma 123
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 120
Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. Int J Obesity 114
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 113
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. 112
p53 regulates the mevalonate pathway in human glioblastoma multiforme. 110
The cannabinoid CB1 receptor antagonist Rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating phosphatidylinositol-3-kinase activity. 108
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. 103
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 101
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake. 100
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 98
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. 96
The right to care and the expectations of society?controversial stem cell therapy in Italy 96
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer 94
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. 94
Cytokine pattern in postmenopause. 93
Statins and cancer in gastroenterology: new insight? 90
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 86
Statins and cancer-related mortality: an open question. 84
Inulin Amphiphilic Copolymer-Based Drug Delivery: Unraveling the Structural Features of Graft Constructs 83
Statins in neurological disorders: an overview and update 83
Formulazione e caratterizzazione di un’emulsione cosmetica a base di un estratto di mela annurca ad attività antiossidante 83
Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins. 82
Cannabinoids and cancer: pros and cons of an antitumour strategy. 80
N(6)-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 80
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 79
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 78
Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines. 78
PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines. 77
Development, characterization, and clinical investigation of a new topical emulsion system containing a castanea sativa spiny burs active extract 75
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 74
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression 74
Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids 74
Synthesis and biological evaluation of Santacruzamate-A based analogues 73
NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity 73
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. 71
Tetra-substituted pyrrole derivatives act as potent activators of p53 in melanoma cells 70
Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. 68
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) 68
The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation. 68
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. 67
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. 65
Heliotropium bacciferum Forssk. (Boraginaceae) extracts: chemical constituents, antioxidant activity and cytotoxic effect in human cancer cell lines 65
Rimonabant-induced apoptosis in leukemia cell lines: Activation of caspase-dependent and -independent pathways 64
Liver p53 expression in patients with HCV-related chronic hepatitis. 63
Oxylipins from Dracontium loretense. 63
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 63
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines 63
HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway. 62
Serum p53 antibodies assessment may help physicians to follow-up patients with Helicobacter pylori infection. 62
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice. 61
Differentiation of myeloid cell lines correlates with a selective expression of RIZ protein. 61
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review). 60
Pressurized hot water extraction of bioactive compounds from artichoke by-products 60
Serum concentration of free T3, free T4 and TSH in healthy children. 59
Un ingrediente fitoattivo da scarti di Castanea sativa 59
Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines. 58
Serum concentrations of intact parathyroid hormone in healthy children.Clin Chem. 2000 Jun;46(6 Pt 1):863-4. No abstract available. 55
p53 and anti-p53 antibodies as possible markers of a switch towards a neoplastic phenotype in patients infected by Helicobacter pylori. 54
Multifaceted role of PRDM proteins in human cancer 52
Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases 52
Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets 51
Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019 51
null 50
Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer". 46
Serum-soluble E-cadherin fragments in lung cancer. 46
Serum anti-p53 antibodies in lung cancer: comparison with established tumor markers. 45
Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. 44
The Endocannabinoid System: A Target for Cancer Treatment 42
Colon Cancer Survival and Statins: What More Evidence Do We Need? 41
In Vitro Evidence of Statins' Protective Role against COVID-19 Hallmarks 40
N6-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression 40
Advances in "adiponcosis": Insights in the inner mechanisms at the base of adipose and tumour tissues interplay 39
N6-isopentenyladenosine inhibits colorectal cancer and improves sensitivity to 5-fluorouracil-targeting FBXW7 tumor suppressor 39
Onion Peel: Turning a Food Waste into a Resource 37
Towards an improvement of anticancer activity of benzyl adenosine analogs 37
The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed 36
PR/SET domain family and cancer: Novel insights from the cancer genome atlas 29
N6-isopentenyladenosine hinders the vasculogenic mimicry in human glioblastoma cells through Src-120 catenin pathway modulation and RhoA activity inhibition 29
New sesquiterpenes from Asteriscus graveolens 27
Association of alpha b-crystallin expression with tumor differentiation grade in colorectal cancer patients 27
Statins in coronavirus outbreak: It's time for experimental and clinical studies 25
Totale 10.534
Categoria #
all - tutte 34.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021671 0 63 59 6 79 33 67 19 75 3 79 188
2021/2022606 2 1 1 14 30 8 4 23 94 77 86 266
2022/20231.135 107 100 17 156 154 227 8 101 161 21 52 31
2023/2024476 38 61 29 34 38 78 11 14 6 27 40 100
2024/20251.368 66 13 54 65 85 120 248 109 180 59 174 195
2025/20263.174 1.808 1.366 0 0 0 0 0 0 0 0 0 0
Totale 10.660